FDA Inspection
Nashat Y Gabrail MDNashat Y Gabrail MD – FDA Inspection, Dec 17, 2009
Record Details
This FDA Inspection record concerns Nashat Y Gabrail MD, with an inspection on December 17, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nashat Y Gabrail MD
- Inspection Date
- December 17, 2009
- Product Type
- Drugs
View Company Profile
ID · 2bce4786-8147-4ea0-8277-7d1c254bd695
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 634783
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.66Changes in research
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nashat Y Gabrail MD
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 15, 2026 | Not classified | Cincinnati District Office | |
| January 23, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 21, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Nashat Y Gabrail MD
- FDA Inspection 1313094 - 2026-04-15
- FDA Inspection 1116861 - 2020-01-23
- FDA Inspection 911090 - 2015-01-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.